av/vivoryon-therapeutics-n-v--big.svg

COM:VIVORYON

Vivoryon Therapeutics AG

  • Stock

Last Close

2.00

22/11 14:58

Market Cap

49.61M

Beta: -

Volume Today

15.40K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.44
-
-0.12
-
cash conversion cycle
113.02
-
2.95K
-
cash per share
1.19
-
4.30
261.38%
3.11
27.75%
2.87
7.55%
1.26
56.27%
0.46
63.33%
3.31
617.89%
1.32
60.20%
0.73
44.34%
1.21
64.51%
company equity multiplier
-1.51
-
1.34
189.13%
1.36
0.77%
1.37
0.77%
1.21
11.69%
3.29
172.87%
1.07
67.34%
1.13
5.56%
1.48
30.52%
1.18
20.06%
1.17
0.91%
days of inventory outstanding
-814.73
-
-624.64
23.33%
-158.40
74.64%
-1.44K
811.72%
days of payables outstanding
10.62
-
7.12
32.91%
1.18
83.37%
12.25
934.28%
2.24
81.75%
2.28
1.87%
0.92
59.70%
5.77
528.18%
-2.95K
51,279.38%
days of sales outstanding
113.94
-
dividend yield
ebit per revenue
-1.19
-
8.10
-
ebt per ebit
1.01
-
1.02
0.41%
1.01
0.66%
1.01
0.01%
0.91
9.28%
1.01
9.88%
1.01
0.12%
1.03
2.43%
0.95
7.40%
0.97
1.98%
0.97
0.09%
effective tax rate
-0.12
-
-0.04
-
0.01
119.86%
0.01
16.68%
enterprise value multiple
-5.57
-
-3.95
29.13%
-5.29
33.96%
-5.85
10.58%
-10.07
72.14%
-13.82
37.17%
-16.50
19.41%
-15.20
7.85%
-20.03
31.74%
-7.00
65.05%
0.64
109.07%
fixed asset turnover
37.77
-
-47.63
-
free cash flow per share
-2.01
-
-2.18
8.62%
-1.77
18.80%
-1.74
1.59%
-1.48
14.93%
-0.85
42.32%
-0.93
8.74%
-0.73
21.02%
-0.56
23.07%
-0.99
75.52%
gross profit margin
0.84
-
0.90
-
interest coverage
-71.98
-
-696.39
867.46%
-533.58
23.38%
-1.21K
127.49%
-63.08
94.80%
inventory turnover
-0.45
-
-0.58
30.43%
-2.30
294.35%
-0.25
89.03%
long term debt to capitalization
net income per ebt
1
-
1
0%
1
0%
1
0%
0.88
12.10%
1
13.76%
1
0%
1
0%
1.04
3.53%
0.99
4.09%
0.99
0.12%
net profit margin
-1.18
-
7.83
-
operating cash flow per share
-2.00
-
-2.18
8.67%
-1.77
18.83%
-1.74
1.59%
-1.48
14.94%
-0.85
42.42%
-0.92
8.55%
-0.70
24.16%
-0.56
19.76%
-0.99
75.85%
operating cycle
113.94
-
operating profit margin
-1.19
-
8.10
-
payables turnover
34.38
-
51.24
49.06%
308.14
501.35%
29.79
90.33%
163.27
448.00%
160.26
1.84%
397.71
148.16%
63.31
84.08%
-0.12
100.20%
pretax profit margin
-1.14
-
7.89
-
price fair value
-13.48
-
4.07
130.23%
5.70
39.90%
6.23
9.24%
12.28
97.23%
89.29
627.22%
3.94
95.59%
10.19
158.99%
16.16
58.56%
8.65
46.49%
receivables turnover
3.20
-
return on assets
-1.53
-
-0.53
65.22%
-0.62
16.00%
-0.62
0.56%
-0.74
19.82%
-1.91
156.83%
-0.17
91.08%
-0.55
225.32%
-0.52
7.00%
-0.90
73.86%
-0.92
2.45%
return on capital employed
3.26
-
-0.67
120.44%
-0.79
18.48%
-0.80
1.25%
-0.99
23.39%
-2.50
152.94%
-0.17
93.07%
-0.56
225.66%
-0.66
16.74%
-1.04
57.54%
-1.06
2.38%
return on equity
2.31
-
-0.72
131.00%
-0.84
16.90%
-0.85
1.33%
-0.90
5.81%
-6.29
600.81%
-0.18
97.09%
-0.63
243.40%
-0.76
21.39%
-1.06
38.98%
-1.08
1.52%
total debt to capitalization
1.02
-
0.00
99.79%
0.00
60.72%
0.01
61.55%
0.00
36.05%
0.00
59.14%

All numbers in (except ratios and percentages)